Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 80 of 80« First...102030...7677787980

New Evidence For How Green Tea And Apples Could Protect Health, Study

Scientists from the Institute of Food Research have found evidence for a mechanism by which certain food compounds could help protect our health. Dietary studies have shown that people who eat the largest amounts of fruit and vegetables have a reduced risk of developing chronic conditions, such as heart disease and cancer. There could be […]

Read More »

Your Pain Reliever May Also Be Diminishing Your Joy, Ohio State University Study

Acetaminophen reduces both pain and pleasure, study finds COLUMBUS, Ohio — Researchers studying the commonly used pain reliever acetaminophen found it has a previously unknown side effect: It blunts positive emotions. In the study, participants who took acetaminophen reported less strong emotions when they saw both very pleasant and very disturbing photos, when compared to […]

Read More »

Eating Out Boosts High Blood Pressure Risk, Study

Eating Out = High Blood Pressure? A recent study on university-going young adults, by researchers from the Duke-NUS Graduate Medical School Singapore (Duke-NUS), is the first ever to show an association between meals eaten away from home and high blood pressure. These findings highlight lifestyle factors that can affect hypertension and emphasise the importance of […]

Read More »

Cancer Linked To Muscle-Building Supplements, Brown University Study

Study Finds Cancer Link For Muscle-Building Supplements A new study associates taking muscle-building supplements with an increased risk of testicular cancer. Men who used such pills and powders were more likely to have developed testicular cancer than those who did not, especially if they started before age 25, took more than one supplement, or used […]

Read More »

Heart chip beats toward better drug screening, personalized medicine

  BERKELEY, CALIFORNIA – Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool   for drug development as well as pave the way toward personalizing treatments for patients with heart conditions.    “It is the first demonstration of […]

Read More »

Experimental Drug That May Repair Nerve Damage in MS Moves Forward

WASHINGTON, April 14, 2015 /PRNewswire-USNewswire/ — A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves and is damaged in MS, according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April […]

Read More »

WHO demands disclosure of all clinical trial results

A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. Reuters/Srdjan Zivulovic (Reuters) – The World Health Organization called on Tuesday for the release of clinical trial results for all drugs, vaccines and medical devices – whatever the result – in the latest salvo against the withholding of […]

Read More »

REGiMMUNE Announces Collaboration With JDRF and Pfizer Inc. for Type 1 Diabetes Prevention and Treatment Promoting Regulatory T-Cells

Antigen-Specific Immunotherapy to Potentially Prevent or Delay Diabetes in Preclinical Model TOKYO, JAPAN–(Marketwired – Apr 14, 2015) – REGiMMUNE Corporation (RGI) and JDRF today announced a partnership, along with financial assistance and scientific expertise from Pfizer Inc., for a research collaboration to develop an antigen-specific immunotherapy utilizing RGI’s proprietary αGalCer/liposome platform for immunological tolerance for […]

Read More »

Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today, Biogen (NASDAQ: BIIB) announced detailed results from the Phase 2 RENEW study of anti-LINGO-1 in acute optic neuritis (AON) – the first clinical study to demonstrate remyelination (the formation of new myelin on axons) following an inflammatory injury in humans. These data will be presented at the 67th Annual Meeting of the […]

Read More »

Divorce tied to increased heart attack risk

  (Reuters Health) – Women who have been divorced once, or men who have been divorced at least twice, are more likely to have a heart attack than people who get and stay married, according to a new study. “The negative health consequences of divorce have been known for some time,” said lead author Matthew […]

Read More »

Celprogen Introduces a Novel Pharmacological Inhibitor CEP1430 for Human Pancreatic Cancer Patients

TORRANCE, Calif.–(BUSINESS WIRE)–Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have developed a novel pharmacological Inhibitor CEP1430 synthetic molecule that is capable of inhibiting the growth and proliferation of the human pancreatic cancer tumor. This molecule can […]

Read More »

FDA Advisory Committee Reviews Takeda’s Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial

DEERFIELD, Ill. and OSAKA, Japan, April 14, 2015 /PRNewswire/ — Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, (“Takeda”) today announced that members of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the United States (U.S.) Food and Drug Administration (FDA) convened to review one of the first cardiovascular (CV) outcomes trials (CVOT) […]

Read More »

GeoVax to Seek Dual Pathway for Advancing Its HIV Preventive Vaccine

Strategy Intended to Accelerate Development of an HIV Vaccine for the Americas and Western Europe ATLANTA, GA–(Marketwired – Apr 14, 2015) – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines for Ebola and HIV using its novel platform technology, today announced its intention to pursue a dual pathway for advancing its […]

Read More »

NorthShore University HealthSystem Launches Comprehensive Center for Personalized Medicine, Ushering in New Era in Medical Care

Trailblazing Initiative to Treat and Prevent Illness Based on Patient’s Genetic, Biologic Makeup EVANSTON, IL–(Marketwired – April 14, 2015) – NorthShore University HealthSystem (NorthShore) today launched one of the most comprehensive personalized medicine programs in the country that utilizes an individual’s health history and DNA to better predict, prevent and diagnose certain diseases, and develop […]

Read More »

Lilly Study: Livalo Helps HIV Patients

New Data Showed Livalo (Pitavastatin) 4 Mg Had Neutral Effects on Fasting Serum Glucose and Hba1c Levels in HIV-Infected Adults With Dyslipidemia Study results presented at ENDO 2013 Annual Meeting SAN FRANCISCO, June 17, 2013 /PRNewswire/ — Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY) announced results of a pre-specified safety analysis […]

Read More »

GlaxoSmithKline: Offsetting Results

GlaxoSmithKline is succeeding with newly launched products and strong R&D flow while struggling with U.S. pricing and competitive pressures.

Read More »

22nd Annual Report 2013

Top 100 Biotechnology Companies

Biotech industry growth is bolstered by increased R&D spending, an upswing of approved first-in-class medicines, elevated Wall Street valuations, and continued forging of pipeline alliances with Big Pharma.

Read More »

Future blockbusters 2013

Click to download the PDF to view the full issue An upswing in NME approvals is an encouraging sign for an industry trying to overcome mega-brand patent expirations and a lag in research and development productivity. R&D expenditure growth for the industry as a whole has reached a stagnant state, though many companies remain dedicated […]

Read More »

Page 80 of 80« First...102030...7677787980

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2017 Focus: Ad Agency Roundtable and more!

Subscribe

Ad Right Bottom

Main Navigation